Affinity DataIC50: 14nMAssay Description:Inhibition of sPLA2 in human HepG2 cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Inhibition of sPLA2 in atherosclerotic plaque from coronary artery disease patientMore data for this Ligand-Target Pair
Affinity DataIC50: 114nMAssay Description:Inhibition of human recombinant sPLA2 assessed as reduction in 16:0 LPC formation after 30 mins by HPLC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 114nMAssay Description:Inhibition of human recombinant sPLA2 assessed as reduction in 16:0 LPC formation after 30 mins by HPLC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 131nMAssay Description:Inhibition of human recombinant sPLA2 assessed as reduction in free FA formation after 30 mins by HPLC-MS analysisMore data for this Ligand-Target Pair
Affinity DataIC50: 131nMAssay Description:Inhibition of human recombinant sPLA2 assessed as reduction in free FA formation after 30 mins by HPLC-MS analysisMore data for this Ligand-Target Pair
TargetO15496/P04054/P14555/P39877/Q5R387/Q9BX93/Q9BZM1/Q9BZM2/Q9NZ20/Q9NZK7/Q9UNK4(Human)
University of Louvain
Curated by ChEMBL
University of Louvain
Curated by ChEMBL
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of human sPLA2More data for this Ligand-Target Pair
